menu
    • menu

    Company profile for Enveric Biosciences

    NEW Drugs in Dev: 6
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions t...
    Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enveric BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4851 Tamiami Trail N, Suite 200 Naples, FL 34103
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enveric.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/envericbio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Enveric_Bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enveric Reports EB-003 BRET Receptor Engagement Assay Data
    Enveric Reports EB-003 BRET Receptor Engagement Assay Data

    19 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260219613461/en/Enveric-Biosciences-Reports-EB-003-BRET-Receptor-Engagement-Assay-Data

    BUSINESSWIRE
    19 Feb 2026
    Share Share
    Enveric Biosciences Expands Collaboration With TOTEC Pharma
    Enveric Biosciences Expands Collaboration With TOTEC Pharma

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129235695/en/Enveric-Biosciences-Expands-Collaboration-with-TOTEC-Pharma-through-Trademark-License-and-Option

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Enveric Biosciences Closes $1.5M Direct Offering Under Nasdaq
    Enveric Biosciences Closes $1.5M Direct Offering Under Nasdaq

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128398397/en/Enveric-Biosciences-Announces-Closing-of-%241.5-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Enveric Biosciences Launches $1.5M At-The-Market Offering
    Enveric Biosciences Launches $1.5M At-The-Market Offering

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128331114/en/Enveric-Biosciences-Announces-%241.5-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Enveric Biosciences Announces Patent Issuance
    Enveric Biosciences Announces Patent Issuance

    29 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251229833047/en/Enveric-Biosciences-Announces-Patent-Issuance

    BUSINESSWIRE
    29 Dec 2025
    Share Share
    Enveric Biosciences Completes $3.1M Warrant Exercise
    Enveric Biosciences Completes $3.1M Warrant Exercise

    12 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251212844550/en/Enveric-Biosciences-Announces-Closing-of-Exercise-of-Warrants-for-%243.1-Million-Gross-Proceeds

    BUSINESSWIRE
    12 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search